Half-year report · Q2

Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥12.9bn2024-10-01 → 2025-03-31Cons.Net sales
Revenue¥19.8bn2023-10-01 → 2024-09-30Cons.Net sales (5-year summary)
Revenue¥12.2bn2023-10-01 → 2024-03-31Cons.Net sales
Operating income¥497m2024-10-01 → 2025-03-31Cons.Operating income
Operating income¥358m2023-10-01 → 2024-03-31Cons.Operating income
Ordinary income¥514m2024-10-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥181m2023-10-01 → 2024-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥358m2023-10-01 → 2024-03-31Cons.Ordinary income
Profit before tax¥514m2024-10-01 → 2025-03-31Cons.Income before income taxes
Profit before tax¥358m2023-10-01 → 2024-03-31Cons.Income before income taxes
Net income (owners)¥344m2024-10-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥136m2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥221m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income¥356m2024-10-01 → 2025-03-31Cons.Profit loss
Net income¥229m2023-10-01 → 2024-03-31Cons.Profit loss
Total assets¥16.1bnat 2025-03-31Cons.Assets
Total assets¥10.7bnat 2024-09-30Cons.Assets
Total assets¥13.5bnat 2024-03-31Cons.Total assets (5-year summary)
Total liabilities¥10.2bnat 2025-03-31Cons.Liabilities
Total liabilities¥4.9bnat 2024-09-30Cons.Liabilities
Net assets / equity¥6.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥5.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥5.9bnat 2024-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.3bnat 2025-03-31Cons.Cash and deposits
Cash and deposits¥5.6bnat 2024-09-30Cons.Cash and deposits
Cash & equivalents¥5.2bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.6bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2023-09-30dCons.Cash and cash equivalents
Operating cash flow−¥87m2024-10-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥33m2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥521m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥123m2024-10-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥101m2023-10-01 → 2024-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥23m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥105m2024-10-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥97m2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥100m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥58.322024-10-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.092023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.492023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥58.082024-10-01 → 2025-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.962023-10-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥37.262023-10-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio36.0%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio52.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-10-01 → 2025-03-31¥1m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue2024-10-01 → 2025-03-31¥193m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue external2024-10-01 → 2025-03-31¥193m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentsegment profit2024-10-01 → 2025-03-31¥2m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥410m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥410m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentsegment profit2024-10-01 → 2025-03-31¥41m
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥12.3bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥12.3bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentsegment profit2024-10-01 → 2025-03-31¥453m
Total Of Reportable Segments And Otherssegment totalrevenue2024-10-01 → 2025-03-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-10-01 → 2025-03-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-10-01 → 2025-03-31¥496m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31¥1m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue2023-10-01 → 2024-03-31¥211m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentrevenue external2023-10-01 → 2024-03-31¥211m
jpcrp040300-q2r_E34455-000Food Servicereportable segmentsegment profit2023-10-01 → 2024-03-31¥7m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥372m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥372m
jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥31m
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥11.6bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥11.6bn
jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segmentsegment profit2023-10-01 → 2024-03-31¥319m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥12.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥12.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥357m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Current fiscal year start dateFilingDateInstant2024-10-01
Current period end dateFilingDateInstant2025-03-31
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2025-09-30
Previous fiscal year start dateFilingDateInstant2023-10-01
Comparative period end dateFilingDateInstant2024-03-31
Previous fiscal year end dateFilingDateInstant2024-09-30
Next fiscal year start dateFilingDateInstant-
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant-
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant-
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所スタンダード市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)株式会社A&M
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)滋賀県守山市勝部2-9-9
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)光通信株式会社
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東京都豊島区西池袋1-4-10
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)株式会社UH Partners 2
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)東京都豊島区南池袋2-9-9
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)レオクラン従業員持株会
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)大阪府摂津市千里丘2-4-26
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)大阪中小企業投資育成株式会社
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)大阪府大阪市北区中之島3-3-23
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)杉田 昭吾
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)滋賀県守山市
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)株式会社UH Partners 3
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東京都豊島区南池袋2-9-9
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)株式会社SBI証券
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)東京都港区六本木1-6-1
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)八上 重明
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)大阪府四条畷市
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)山森 正雄
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)東京都中央区
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-09-30pass
balance sheet identityconsolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-10-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2024-10-01/2025-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2024-10-01/2025-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass